It has been found that DNAJB6 negatively affected cancer properties, and a loss of DNAJB6 would lead to tumor growth, epithelial–mesenchymal transition (EMT), and metastasis by aberrantly activating Wnt/β-catenin signaling during breast cancer progression [47]. This evidence concerns the gene DNAJB6 and breast cancer.